MAP7D3 and breast carcinoma: Moreover, MAP7D3 depletion could significantly retard primary tumor growth and inhibit lung metastasis capability of metastatic TNBC cells in the orthotopic breast cancer mouse model and tail-vein injection mouse model, respectively (Fig. 4).